Yi Chen, Ph.D., CFA, is a Managing Director of Equity Research at H.C. Wainwright since 2015 and his research primarily covers investment opportunities in the U.S. healthcare industry. Prior to joining H.C. Wainwright, Dr. Chen worked as an Associate Director of Equity Research at Aegis Capital Corp. and as a Research Associate at Morgan Joseph TriArtisan, LLC. Dr. Chen also worked as a Trading Associate at Zhang Capital Management, a New York-based buy-side fund. Prior to that, Dr. Chen was a Research Associate at the City University of New York where his research focused primarily on protein signaling domains utilizing an RNA interference approach. Dr. Chen holds a Ph.D. degree in biochemistry from the City University of New York and he is also a Chartered Financial Analyst (CFA) charterholder.